Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALStandard

TERCONAZOLE

TERCONAZOLE

Standard Dose
0.8%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TERCONAZOLE is listed in Drugs@FDA under application 075953 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TERCONAZOLE Form and strength CREAM;VAGINAL - 0.8% Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2015-08-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview TERCONAZOLE is listed in Drugs@FDA under application 075953 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TERCONAZOLE Form and strength CREAM;VAGINAL - 0.8% Sponsor SUN PHARMA CANADA Submission history Latest submission status date: 2015-08-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.